Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1998-08-26
2000-02-29
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4242501, 4242571, 436506, 436811, 514 18, 514 19, 530331, 548159, 548180, 548217, 5483044, 5483061, 5483097, 548458, 548491, 564153, 562 26, 562433, 562450, A61K 3805, A61K 3806, A61K 39095, C07K 5062, C07K 5083
Patent
active
06030619&
ABSTRACT:
Molecular mimetics of unique epitopes of Neisseria meningitidis serogroup B ("MenB") are disclosed. Compositions containing such molecular mimetics can be used to prevent MenB or E. coli K1 disease without the risk of evoking autoantibody responses.
REFERENCES:
patent: 4727136 (1988-02-01), Jennings
patent: 5475106 (1995-12-01), Boorzat et al.
patent: 5556757 (1996-09-01), Alstyne et al.
Figliozzi et al., "Synthesis of N-Substituted Glycine Peptoid Libraries," Methods in Enzymology 267:437-447(1996).
Granoff et al., "Antibody Responses to the Capsular Polysaccharide of Neisseria meningitidis Serogroup B in Patients with Meningococcal Disease," Clinical and Diagnostic Laboratory Immunology 2(5):574-582 (1995).
Granoff et al., "Bactericidal Monoclonal Antibodies That Define Unique Meningococcal B Polysaccharide Epitopes That Do Not Cross-React with Human Polysialic Acid," The Journal of Immunology 160:5028-5036 (1998).
Jennings et al., "Induction of Meningococcal Group B Polysaccharide-Specific IgG Antibodies in Mice by Using an N-Propionylated B Polysaccharide-Tetanus Toxoid Conjugate Vaccine," The J. Of Immunology 137(5):1708-1713(1986).
Jennings et al., "N-Propionylated Group B Meningococcal Polysaccharide Mimics a Unique Epitope on Group B Neisseria Meningitidis," J. Experimental Medicine 165:1207-1211 (1987).
Westerink et al., "Development and Characterization of an Anti-Idiotype Antibody to the Capsular Polysaccharide of Neisseria Mengingitidis Serogroup C," Infection and Immunity 56(5):1120-1127 (1988).
Westerlink et al., "Peptide Mimicry of the Menigococcal Group C Capsular Polyasccharide," Proc. Nat. Acad. Sci. USA 92:4021-4025 (1995).
Zuckermann et al., "Design, Construction and Application of a Fully Automated Equimolar Peptide Mixture Synthesizer," Pept. Protein Res. 40:498 (1992).
Chemical Abstract 113:231990r, p. 784, 1990.
Zuckermann et al, Discovery of Nanomolar Ligands . . . J. Med. Chem. vol. 37, pp. 2678-2685, 1994.
Granoff Dan M.
Moe Gregory R.
Blackburn Robert P.
Chiron Corporation
Harbin Alisa A.
Robins Roberta L.
Russel Jeffrey E.
LandOfFree
Molecular mimetics of meningococcal B epitopes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Molecular mimetics of meningococcal B epitopes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecular mimetics of meningococcal B epitopes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-680243